A Phase III Randomized, Double-Blind Study Comparing Human Corticotropin-Releasing Factor (hCRF) to Dexamethasone for Control of Symptoms Associated With Peritumoral Brain Oedema in Patients With Primary Malignant Glioma

Trial Profile

A Phase III Randomized, Double-Blind Study Comparing Human Corticotropin-Releasing Factor (hCRF) to Dexamethasone for Control of Symptoms Associated With Peritumoral Brain Oedema in Patients With Primary Malignant Glioma

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 12 Apr 2014

At a glance

  • Drugs Corticorelin (Primary) ; Dexamethasone
  • Indications Brain oedema
  • Focus Registrational; Therapeutic Use
  • Sponsors Celtic Pharma
  • Most Recent Events

    • 12 Apr 2014 New trial record
    • 02 Jan 2008
    • 11 Feb 2006
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top